Suppr超能文献

AMDA类似物在5-HT2A和H1受体上的合成、结构-亲和力关系及建模:影响选择性的结构因素

Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.

作者信息

Shah Jitesh R, Mosier Philip D, Roth Bryan L, Kellogg Glen E, Westkaemper Richard B

机构信息

Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, PO Box 980540, Richmond, VA 23298, USA.

出版信息

Bioorg Med Chem. 2009 Sep 15;17(18):6496-504. doi: 10.1016/j.bmc.2009.08.016. Epub 2009 Aug 13.

Abstract

Histamine H(1) and serotonin 5-HT(2A) receptors present in the CNS have been implicated in various neuropsychiatric disorders. 9-Aminomethyl-9,10-dihydroanthracene (AMDA), a conformationally constrained diarylalkyl amine derivative, has affinity for both of these receptors. A structure-affinity relationship (SAFIR) study was carried out studying the effects of N-methylation, varying the linker chain length and constraint of the aromatic rings on the binding affinities of the compounds with the 5-HT(2A) and H(1) receptors. Homology modeling of the 5-HT(2A) and H(1) receptors suggests that AMDA and its analogs, the parent of which is a 5-HT(2A) antagonist, can bind in a fashion analogous to that of classical H(1) antagonists whose ring systems are oriented toward the fifth and sixth transmembrane helices. The modeled orientation of the ligands are consistent with the reported site-directed mutagenesis data for 5-HT(2A) and H(1) receptors and provide a potential explanation for the selectivity of ligands acting at both receptors.

摘要

中枢神经系统中存在的组胺H(1)受体和5-羟色胺5-HT(2A)受体与多种神经精神疾病有关。9-氨基甲基-9,10-二氢蒽(AMDA)是一种构象受限的二芳基烷基胺衍生物,对这两种受体都具有亲和力。开展了一项结构-亲和力关系(SAFIR)研究,考察了N-甲基化、改变连接链长度以及芳香环的限制对化合物与5-HT(2A)和H(1)受体结合亲和力的影响。5-HT(2A)和H(1)受体的同源性建模表明,AMDA及其类似物(其母体是一种5-HT(2A)拮抗剂)能够以类似于其环系统朝向第五和第六跨膜螺旋的经典H(1)拮抗剂的方式结合。配体的模拟取向与报道的5-HT(2A)和H(1)受体定点诱变数据一致,并为作用于这两种受体的配体的选择性提供了一种潜在解释。

相似文献

3
9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.
Bioorg Med Chem Lett. 2010 Feb 1;20(3):935-8. doi: 10.1016/j.bmcl.2009.12.064. Epub 2009 Dec 23.
5
Methoxy-substituted 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives exhibit differential binding affinities at the 5-HT(2A) receptor.
Bioorg Med Chem Lett. 2008 Oct 1;18(19):5268-71. doi: 10.1016/j.bmcl.2008.08.059. Epub 2008 Aug 22.
6
Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist.
Eur J Pharmacol. 2003 Dec 15;482(1-3):335-7. doi: 10.1016/j.ejphar.2003.09.059.
8
9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.
Eur J Pharmacol. 1999 Sep 3;380(1):R5-7. doi: 10.1016/s0014-2999(99)00525-7.

引用本文的文献

1
Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step.
Viruses. 2021 Nov 19;13(11):2306. doi: 10.3390/v13112306.
4
Affinity of aporphines for the human 5-HT2A receptor: insights from homology modeling and molecular docking studies.
Bioorg Med Chem. 2010 Aug 1;18(15):5562-75. doi: 10.1016/j.bmc.2010.06.043. Epub 2010 Jun 20.
5
9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.
Bioorg Med Chem Lett. 2010 Feb 1;20(3):935-8. doi: 10.1016/j.bmcl.2009.12.064. Epub 2009 Dec 23.

本文引用的文献

1
The expanded biology of serotonin.
Annu Rev Med. 2009;60:355-66. doi: 10.1146/annurev.med.60.042307.110802.
4
Privileged structures: a useful concept for the rational design of new lead drug candidates.
Mini Rev Med Chem. 2007 Nov;7(11):1108-19. doi: 10.2174/138955707782331722.
5
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.
Science. 2007 Nov 23;318(5854):1258-65. doi: 10.1126/science.1150577. Epub 2007 Oct 25.
6
New perspectives for the treatment of disorders of sleep and arousal.
Ann Pharm Fr. 2007 Jul;65(4):268-74. doi: 10.1016/s0003-4509(07)90046-2.
7
Histaminergic control of sleep-wake cycles: recent therapeutic advances for sleep and wake disorders.
CNS Neurol Disord Drug Targets. 2007 Feb;6(1):31-43. doi: 10.2174/187152707779940790.
9
The histamine H4 receptor as a new therapeutic target for inflammation.
Trends Pharmacol Sci. 2005 Sep;26(9):462-9. doi: 10.1016/j.tips.2005.07.002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验